US Trials New Personalized Vaccine to Reduce Skin Cancer Recurrence Risk by 42%

A new personalized vaccine designed to reduce the risk of skin cancer recurrence after surgery has been tested in the US. The vaccine, prepared individually for each patient, has shown a 42% reduction in the risk of cancer returning. Further details are available on daryo.uz.

Read the full article at Daryo.uz (Toshkent) →

Headline and summary written by daryo. The full report belongs to Daryo.uz (Toshkent).